Antibiotic Companies To Cash In On In 2014
moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
DRTX
Durata Therapeutics prices $46M stock offering
moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
Durata Therapeutics 7.15M share Secondary priced at $7.00
moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
3 Speculative Healthcare Companies With High Levels Of Insider Ownership – Part III
moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
Durata Therapeutics, Inc. Reports Full-Year 2012 Financial Results
[at noodls] – Download PDF Entered Into a $20 Million Debt Facility CHICAGO, March 8, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced financial results for the year ended December 31, … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
Durata Therapeutics to Announce Full Year 2012 Financial Results on Friday, March 8, 2013
[at noodls] – Download PDF Conference Call to Be Held at 8:30 a.m. Eastern Time CHICAGO, March 5, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics (Nasdaq:DRTX) has scheduled its quarterly conference call for Friday, March … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to […]
Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI
[at noodls] – Download PDF DISCOVER 2 Study Meets Primary & Secondary Endpoints Conference Call and Webcast Today at 8:30 A.M. EST to Discuss Results CHICAGO, Feb. 25, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here […]
Durata Therapeutics to Present at the Cowen & Company 33rd Annual Health Care Conference
[at noodls] – Download PDF CHICAGO, Feb. 20, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics (Nasdaq:DRTX) today announced that Durata’s Chief Executive Officer Paul R. Edick will present an overview of the company at … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
Durata Therapeutics to Present at the 2013 RBC Capital Markets’ Global Healthcare Conference
[at noodls] – Download PDF CHICAGO, Feb. 13, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics (Nasdaq:DRTX) today announced the company will participate in the RBC Capital Markets’ Global Healthcare Conference scheduled … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
Durata Therapeutics Meets Primary Endpoints for EMA Review in Phase 3 Clinical Trial
[at noodls] – Download PDF CHICAGO, Jan. 4, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced additional preliminary, top-line results for its DISCOVER 1 (Dalbavancin for Infections … moreView todays social media effects on DRTXView the latest stocks trending across Twitter. Click to view dashboardSee who Durata is hiring next, click here to view […]
